Pharma

May 6 2018

In Guilty Plea, OxyContin Maker to Pay $600 Million – The New York Times, purdue pharmaceuticals.#Purdue #pharmaceuticals

In Guilty Plea, OxyContin Maker to Pay $600 Million ABINGDON, Va., May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential to be abused. To resolve criminal and civil charges related to the drug’s “misbranding,” the parent of Purdue Pharma, the company that markets OxyContin, agreed to pay some $600 million in fines and other payments, one of the largest amounts ever paid by a drug company …

May 6 2018

Purdue Pharma, Geisinger s study of Apple Watches for chronic pain therapy begins enrollment, MobiHealthNews, purdue pharmaceuticals.#Purdue #pharmaceuticals

purdue pharmaceuticals Purdue Pharma and Geisinger announced today that the first patient has been enrolled in the companies’ upcoming trial of medical wearables as an alternative therapy for chronic pain. The ResearchKit study looks to see how wearables (in this case, the Apple Watch) can alleviate pain without relying on pharmaceutical painkillers, a commendable goal for a company whose painkilling opioid OxyContin has been at the heart of the US’ ongoing opioid epidemic. “What we are really looking at is whether we can we decrease pain, improve functioning, and reduce reliance on pain medication,” Dr. Tracy Mayne, Purdue’s head of …

May 3 2018

Apply for More Aid – Division of Financial Aid – Purdue University, purdue pharmaceutical.#Purdue #pharmaceutical

Apply for More The FAFSA registers you to be considered for aid from Purdue and the federal/state government. To be considered for additional Purdue/private scholarships or private loans, you need to take a few extra steps, such as completing a separate application. Additional information about eligibility and steps to apply for each type of resource are listed below: Purdue Departmental Scholarships *Incoming Polytechnic Institute Statewide students should continue to apply through August 1, 2018. In addition to having a complete admissions application by November 1, new students enrolling in one of the following colleges or schools listed below should also …

May 3 2018

Ohio attorney general sues 5 pharmaceutical companies over opioid epidemic – ABC News, purdue pharmaceutical.#Purdue #pharmaceutical

Sections Yahoo!-ABC News Network | 2017 ABC News Internet Ventures. All rights reserved. Ohio attorney general sues 5 drugmakers over opioid epidemic Play Brooke LaValley/The Columbus Dispatch via AP 0 Shares The Ohio attorney general has filed a lawsuit against five leading prescription opioid manufacturers, alleging that the companies intentionally misled patients regarding the risks and benefits of opioid use with fraudulent marketing. Attorney General Mike DeWine accused the companies of leading patients to believe that opioids were not addictive, which the lawsuit says fueled the current opioid epidemic in Ohio. “We believe the evidence will also show that these …

Feb 20 2018

Apply for More Aid – Division of Financial Aid – Purdue University, purdue pharmaceutical.#Purdue #pharmaceutical

Apply for More The FAFSA registers you to be considered for aid from Purdue and the federal/state government. To be considered for additional Purdue/private scholarships or private loans, you need to take a few extra steps, such as completing a separate application. Additional information about eligibility and steps to apply for each type of resource are listed below: Purdue Departmental Scholarships *Incoming Polytechnic Institute Statewide students should continue to apply through August 1, 2018. In addition to having a complete admissions application by November 1, new students enrolling in one of the following colleges or schools listed below should also …

Feb 20 2018

CBC News – OxyContin maker agrees to settlement in Canadian class-action case, purdue pharmaceutical.#Purdue #pharmaceutical

Claim against Purdue Pharma alleged that company had been ‘overmarketing’ painkiller Posted:May 01, 2017 2:37 PM ET OxyContin was aggressively marketed as a revolutionary painkiller. But many Canadians became addicted. CBC Related Related Stories OxyContin maker Purdue Pharma has agreed to pay $20 million to settle a class-action lawsuit involving allegations about how the pain pills were marketed. “A Canada-wide settlement has been reached in a long-standing class action based on allegations relating to OxyContin. By resolving the suit, Purdue Pharma (Canada) makes no admissions of liability,” Sarah Manley Robertson, director of communications, said in an email on Monday. The …

Jan 13 2018

In Guilty Plea, OxyContin Maker to Pay $600 Million, purdue pharmaceuticals.#Purdue #pharmaceuticals

The New York Times ABINGDON, Va., May 10 — The company that makes the narcotic painkiller OxyContin and three current and former executives pleaded guilty today in federal court here to criminal charges that they misled regulators, doctors and patients about the drug’s risk of addiction and its potential to be abused. To resolve criminal and civil charges related to the drug’s “misbranding,” the parent of Purdue Pharma, the company that markets OxyContin, agreed to pay some $600 million in fines and other payments, one of the largest amounts ever paid by a drug company in such a case. Also, …

Jan 11 2018

CBC News – OxyContin maker agrees to settlement in Canadian class-action case, purdue pharmaceutical.#Purdue #pharmaceutical

Claim against Purdue Pharma alleged that company had been ‘overmarketing’ painkiller Posted:May 01, 2017 2:37 PM ET OxyContin was aggressively marketed as a revolutionary painkiller. But many Canadians became addicted. CBC Related Related Stories OxyContin maker Purdue Pharma has agreed to pay $20 million to settle a class-action lawsuit involving allegations about how the pain pills were marketed. “A Canada-wide settlement has been reached in a long-standing class action based on allegations relating to OxyContin. By resolving the suit, Purdue Pharma (Canada) makes no admissions of liability,” Sarah Manley Robertson, director of communications, said in an email on Monday. The …

Jan 7 2018

Purdue Pharmaceuticals Misled Doctors About OxyContin #acceleron #pharma

#purdue pharmaceuticals # Purdue Pharmaceuticals Misled Doctors about Its Bestselling Painkiller One of the most commonly abused prescription drugs in U.S. history rose to prominence based on a lie, an investigative report by The Los Angeles Times discovered. The Los Angeles Times report found that not only did Purdue Pharma, the makers of OxyContin, provide incomplete information to the FDA, they also falsely marketed the drug as having much longer lasting effects than were demonstrated during clinical trials. Many believe that OxyContin, a powerful, bestselling painkiller, is partially responsible for America’s prescription opioid epidemic. Purdue insisted that the drug relieved …

Dec 27 2017

Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #q #pharma

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …